MyMedR

Displaying all 4 publications

Abstract:

Sort:

Fulltext Recent Advances in Enzymes for the Bioremediation of Pollutants

Mousavi SM, Hashemi SA, Iman Moezzi SM, Ravan N, Gholami A, Lai CW, et al.

Biochem Res Int, 2021;2021:5599204.
PMID: 34401207 DOI: 10.1155/2021/5599204

Nowadays, pollution of the environment is a huge problem for humans and other organisms' health. Conventional methods of pollutant removal like membrane filtration or ion exchange are not efficient enough to lower the number of pollutants to standard levels. Biological methods, because of their higher efficiency and biocompatibility, are preferred for the remediation of pollutants. These cost-effective and environment-friendly methods of reducing pollutants are called bioremediation. In bioremediation methods, enzymes play the most crucial role. Enzymes can remedy different types of organic and inorganic pollutants, including PAHs, azo dyes, polymers, organocyanides, lead, chromium, and mercury. Different enzymes isolated from various species have been used for the bioremediation of pollutants. Discovering new enzymes and new subtypes with specific physicochemical characteristics would be a promising way to find more efficient and cost-effective tools for the remediation of pollutants.
Fulltext Recent Advancements in Polythiophene-Based Materials and their Biomedical, Geno Sensor and DNA Detection

Mousavi SM, Hashemi SA, Bahrani S, Yousefi K, Behbudi G, Babapoor A, et al.

Int J Mol Sci, 2021 Jun 25;22(13).
PMID: 34202199 DOI: 10.3390/ijms22136850

In this review, the unique properties of intrinsically conducting polymer (ICP) in biomedical engineering fields are summarized. Polythiophene and its valuable derivatives are known as potent materials that can broadly be applied in biosensors, DNA, and gene delivery applications. Moreover, this material plays a basic role in curing and promoting anti-HIV drugs. Some of the thiophene's derivatives were chosen for different experiments and investigations to study their behavior and effects while binding with different materials and establishing new compounds. Many methods were considered for electrode coating and the conversion of thiophene to different monomers to improve their functions and to use them for a new generation of novel medical usages. It is believed that polythiophenes and their derivatives can be used in the future as a substitute for many old-fashioned ways of creating chemical biosensors polymeric materials and also drugs with lower side effects yet having a more effective response. It can be noted that syncing biochemistry with biomedical engineering will lead to a new generation of science, especially one that involves high-efficiency polymers. Therefore, since polythiophene can be customized with many derivatives, some of the novel combinations are covered in this review.
Hybrid of sodium polytungstate polyoxometalate supported by the green substrate for photocatalytic degradation of auramine-O dye

Mousavi SM, Hashemi SA, Bahrani S, Mosleh S, Chiang WH, Yousefi K, et al.

Environ Sci Pollut Res Int, 2022 Aug;29(37):56055-56067.
PMID: 35325383 DOI: 10.1007/s11356-022-19767-x

Nowadays, textile industries have severely polluted the ecosystem and water sources via disposal of highly thermo- and photo-stable dyes within the ecology that require practical strategies to remove them from nature. In studies, the photocatalytic disinfection technique has been shown to have widespread applications in indoor air, environmental health, detection, biological, biomedical, laboratory hospital, pharmaceutical food industry, plant safety, waste water, effluents disposal, and drinking water disinfection. Herein, the sodium polytungstate (SPT) polyoxometalate (POM) was synthesized through a multi-step production procedure and hence modified via employing a green protocol by using tartaric acid, glutamic acid, and kombucha solvent toward efficient and total complete removal of the highly toxic, stable, and carcinogenic auramine-O (AO) dye from aqueous media. In this regard, developed materials were well-characterized, and their photocatalysis performance for photodegradation of AO dye was examined. Achieved results showed that the optimum absorption conditions were achieved at pH of 5.0, 15 mg/L of AO concentration, 0.04 g of photocatalyst dosage, and 110 min irradiation time, where SPT and modified SPT via green protocol showed full desirability (desirability function (DF) index of 1) along with 71.75 and 100% removal percentage, respectively. Obtained results justified the superior photocatalytic role of the SPT POM and its derived nanocluster that can be used for the complete removal of highly stable dyes from aqueous media till reaching the drinking water standard.
Global Burden of Elevated LDL-C: Findings From the Global Burden of Disease Study 2023

GBD 2023 LDL Cholesterol Collaborators, Razo C, DeCleene NK, Johnson CO, Stark BA, LeGrand K, et al.

JAMA, 2026 Aug 25;336(8):673-698.
PMID: 42525403 DOI: 10.1001/jama.2026.8628

IMPORTANCE: Elevated low-density lipoprotein cholesterol (LDL-C) is a modifiable risk factor for cardiovascular disease, the leading cause of premature death worldwide. Assessing the LDL-C-related burden is critical for guiding prevention and treatment strategies.
OBJECTIVES: To estimate the global, regional, and national burden of ischemic heart disease and ischemic stroke attributable to elevated LDL-C (relative to 35-54 mg/dL) from 1990 to 2023 and to quantify the contributions of population growth, aging, risk-deleted burden, and exposure changes to burden trends.
DESIGN, SETTING, AND POPULATION: This comparative risk assessment, part of the Global Burden of Disease Study 2023, estimated population-level LDL-C exposure and associated health loss in 204 countries and territories. Mean LDL-C levels were estimated using spatiotemporal gaussian process regression based on 806 studies across 161 countries. Relative risks were derived from meta-analyses of 38 randomized clinical trials. Population-attributable fractions for deaths and disability-adjusted life-years (DALYs) were estimated by age and sex for adults aged 25 years or older from 1990 to 2023, with 95% uncertainty intervals.
EXPOSURE: Population-level LDL-C concentrations.
MAIN OUTCOMES AND MEASURES: Population-attributable fractions, counts, and rates (all ages and age standardized per 100 000) of LDL-C-attributable deaths and DALYs from ischemic heart disease and ischemic stroke, with uncertainty intervals.
RESULTS: In 2023, elevated LDL-C accounted for 3.6 million deaths (95% uncertainty interval, 2.2-5.4 million; 6.0% of global mortality) and 90.7 million DALYs (95% uncertainty interval, 58.9-123.3 million; 3.2% of DALYs). Although global all-ages rates remained stable, age-standardized death and DALY rates decreased by 45.6% and 39.5%, respectively, since 1990. In 2023, age-standardized LDL-C-attributable DALY rates were highest in Eastern Europe and lowest in high-income Asia-Pacific. One-third of the global LDL-C burden occurred in India and China. Population growth and aging drove the increasing burden, with notable regional disparities in LDL-C exposure and risk-deleted DALY rates shifting toward middle-sociodemographic settings.
CONCLUSIONS AND RELEVANCE: Despite declining age-standardized rates, the absolute LDL-C burden has increased since 1990 due to demographic changes and has shifted toward middle-sociodemographic countries. Measurement and surveillance gaps persist. Strengthened prevention, diagnosis, and treatment access strategies are essential to mitigate the health burden of LDL-C.